A benchmark study of loop modeling methods applied to G protein-coupled receptors

G protein-coupled receptors (GPCR) are important drug discovery targets. Despite progress, many GPCR structures have not yet been solved. For these targets, comparative modeling is used in virtual ligand screening to prioritize experimental efforts. However, the structure of extracellular loop 2 (ECL2) is often poorly predicted. This is significant due to involvement of ECL2 in ligand binding for many Class A GPCR. Here we examine the performance of loop modeling protocols available in the Rosetta (cyclic coordinate descent [CCD], KIC with fragments [KICF] and next generation KIC [NGK]) and Molecular Operating Environment (MOE) software suites (de novo search). ECL2 from GPCR crystal structures served as the structure prediction targets and were divided into four sets depending on loop length. Results suggest that KICF and NGK sampled and scored more loop models with sub-angstrom and near-atomic accuracy than CCD or de novo search for loops of 24 or fewer residues. None of the methods were able to sample loop conformations with near-atomic accuracy for the longest targets ranging from 25 to 32 residues based on 1000 models generated. For these long loop targets, increased conformational sampling is necessary. The strongly conserved disulfide bond between Cys3.25 and Cys45.50 in ECL2 proved an effective filter. Setting an upper limit of 5.1 Å on the S–S distance improved the lowest RMSD model included in the top 10 scored structures in Groups 1–4 on average between 0.33 and 1.27 Å. Disulfide bond formation and geometry optimization of ECL2 provided an additional incremental benefit in structure quality.

[1]  Oliver P. Ernst,et al.  Crystal structure of metarhodopsin II , 2011, Nature.

[2]  Hualiang Jiang,et al.  Structure of the full-length glucagon class B G protein-coupled receptor , 2017, Nature.

[3]  K. Garcia,et al.  Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.

[4]  J. Wess,et al.  Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.

[5]  Gebhard F. X. Schertler,et al.  The 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor , 2014, PloS one.

[6]  R. Stenkamp Alternative models for two crystal structures of bovine rhodopsin , 2008, Acta crystallographica. Section D, Biological crystallography.

[7]  David Baker,et al.  High-Resolution Modeling of Transmembrane Helical Protein Structures from Distant Homologues , 2014, PLoS Comput. Biol..

[8]  Hualiang Jiang,et al.  Agonist-bound structure of the human P2Y12 receptor , 2014, Nature.

[9]  J. Pantel,et al.  Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. , 2006, The Journal of clinical investigation.

[10]  Matthew J. O’Meara,et al.  Combined covalent-electrostatic model of hydrogen bonding improves structure prediction with Rosetta. , 2015, Journal of chemical theory and computation.

[11]  Gebhard F. X. Schertler,et al.  Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.

[12]  Charles L. Brooks,et al.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.

[13]  Yoshinori Shichida,et al.  Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Gudermann,et al.  Receptors and G proteins as primary components of transmembrane signal transduction , 1995, Journal of Molecular Medicine.

[15]  E. Coutsias,et al.  Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling , 2009, Nature Methods.

[16]  Christopher G. Tate,et al.  Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol , 2012, Structure.

[17]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[18]  Chris de Graaf,et al.  Structure of the human glucagon class B G-protein-coupled receptor , 2013, Nature.

[19]  K. Diederichs,et al.  In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures , 2016, Acta crystallographica. Section D, Structural biology.

[20]  Christopher I. Bayly,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..

[21]  Christopher G. Tate,et al.  Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design , 2013, Journal of medicinal chemistry.

[22]  T. Nanevicz,et al.  Thrombin Receptor Activating Mutations , 1996, The Journal of Biological Chemistry.

[23]  Vadim Cherezov,et al.  A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.

[24]  Cheng Zhang,et al.  Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.

[25]  M. Congreve,et al.  Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.

[26]  R. Abagyan,et al.  Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV , 2017, Immunity.

[27]  Hualiang Jiang,et al.  Two disparate ligand-binding sites in the human P2Y1 receptor , 2015, Nature.

[28]  Jonathan S. Mason,et al.  Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design , 2012, Journal of medicinal chemistry.

[29]  Brian K. Kobilka,et al.  N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor , 2012, PloS one.

[30]  Roland L. Dunbrack,et al.  The Rosetta all-atom energy function for macromolecular modeling and design , 2017, bioRxiv.

[31]  Chris de Graaf,et al.  Generic GPCR residue numbers - aligning topology maps while minding the gaps. , 2015, Trends in pharmacological sciences.

[32]  Ruben Abagyan,et al.  Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. , 2011, Structure.

[33]  Jonathan A. Javitch,et al.  Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.

[34]  David Baker,et al.  Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.

[35]  X. Deupí,et al.  Structural role of the T94I rhodopsin mutation in congenital stationary night blindness , 2016, EMBO reports.

[36]  Alexander S. Rose,et al.  Crystal structure of a common GPCR-binding interface for G protein and arrestin , 2014, Nature Communications.

[37]  M. Sansom,et al.  Structural basis for Smoothened regulation by its extracellular domains , 2016, Nature.

[38]  Jillian Baker,et al.  Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol–Bound β1-Adrenergic Receptor , 2015, Molecular Pharmacology.

[39]  Amelie Stein,et al.  Improvements to Robotics-Inspired Conformational Sampling in Rosetta , 2013, PloS one.

[40]  Krzysztof Palczewski,et al.  Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.

[41]  Arthur Christopoulos,et al.  Prediction of Loops in G Protein-Coupled Receptor Homology Models: Effect of Imprecise Surroundings and Constraints , 2016, J. Chem. Inf. Model..

[42]  Jie Yin,et al.  High-resolution crystal structure of the human CB1 cannabinoid receptor , 2016, Nature.

[43]  Anton Barty,et al.  Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography , 2014, Nature Communications.

[44]  T. Ceska,et al.  Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket , 2017, Proceedings of the National Academy of Sciences.

[45]  Roland L. Dunbrack,et al.  Nonplanar peptide bonds in proteins are common and conserved but not biased toward active sites , 2011, Proceedings of the National Academy of Sciences.

[46]  Jianyun Huang,et al.  Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State , 2013, Nature Structural &Molecular Biology.

[47]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[48]  S. P. Andrews,et al.  Extra-helical binding site of a glucagon receptor antagonist , 2016, Nature.

[49]  David E. Kim,et al.  Simultaneous Optimization of Biomolecular Energy Functions on Features from Small Molecules and Macromolecules. , 2016, Journal of chemical theory and computation.

[50]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[51]  A. IJzerman,et al.  Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength. , 2016, Journal of medicinal chemistry.

[52]  B. Krumm,et al.  Structural prerequisites for G-protein activation by the neurotensin receptor , 2015, Nature Communications.

[53]  Vadim Cherezov,et al.  Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs , 2014, Nature Communications.

[54]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.

[55]  Liaoyuan A. Hu,et al.  Structural Basis for Apelin Control of the Human Apelin Receptor. , 2017, Structure.

[56]  S. Rasmussen,et al.  Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.

[57]  Xavier Deupi,et al.  Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II , 2011, Proceedings of the National Academy of Sciences.

[58]  S. Iwata,et al.  G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.

[59]  Albert C. Pan,et al.  Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.

[60]  Anton Barty,et al.  Structural basis for bifunctional peptide recognition at human δ-Opioid receptor , 2015, Nature Structural &Molecular Biology.

[61]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[62]  C. Makino,et al.  Binding of more than one retinoid to visual opsins. , 2010, Biophysical journal.

[63]  A. Sali,et al.  Protein Structure Prediction and Structural Genomics , 2001, Science.

[64]  S. Rasmussen,et al.  Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.

[65]  Chris de Graaf,et al.  Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators , 2017, Nature.

[66]  Gert Vriend,et al.  Alpha-Bulges in G Protein-Coupled Receptors , 2014, International journal of molecular sciences.

[67]  D. Veprintsev,et al.  Insights into congenital stationary night blindness based on the structure of G90D rhodopsin , 2013, EMBO reports.

[68]  Arthur Christopoulos,et al.  Crystal structures of the M1 and M4 muscarinic acetylcholine receptors , 2016, Nature.

[69]  N. Vaidehi,et al.  Structure and dynamics of a constitutively active neurotensin receptor , 2016, Scientific Reports.

[70]  Arthur Christopoulos,et al.  Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity , 2017, Cell.

[71]  R. Abagyan,et al.  Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. , 2010, Journal of the American Chemical Society.

[72]  Andreas Plückthun,et al.  Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli , 2014, Proceedings of the National Academy of Sciences.

[73]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[74]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[75]  Patrik Johansson,et al.  Structural insight into allosteric modulation of protease-activated receptor 2 , 2017, Nature.

[76]  Christopher G. Tate,et al.  Structure of the adenosine A(2A) receptor bound to an engineered G protein (vol 536, pg 104, 2016) , 2016 .

[77]  Steven M. Moss,et al.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug , 2014, Nature.

[78]  R. Read,et al.  Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal 
Structures , 2017, Current molecular pharmacology.

[79]  A. Leslie,et al.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.

[80]  Adrian A Canutescu,et al.  Cyclic coordinate descent: A robotics algorithm for protein loop closure , 2003, Protein science : a publication of the Protein Society.

[81]  R. Stevens,et al.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.

[82]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[83]  M. Rudd,et al.  Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.

[84]  Aashish Manglik,et al.  Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation , 2016, Nature.

[85]  Sebastian Kmiecik,et al.  Structure Prediction of the Second Extracellular Loop in G-Protein-Coupled Receptors , 2014, Biophysical journal.

[86]  Shan Jiang,et al.  Crystal structures of agonist-bound human cannabinoid receptor CB1 , 2017, Nature.

[87]  R. Stevens,et al.  Crystal Structure of the Human Cannabinoid Receptor CB1 , 2016, Cell.

[88]  Sujata Sharma,et al.  Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40 , 2017, Nature Structural &Molecular Biology.

[89]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[90]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[91]  Ron O. Dror,et al.  High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar , 2012, Nature.

[92]  Christopher G. Tate,et al.  The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.

[93]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[94]  K. Nechvíle The High Resolution , 2005 .

[95]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[96]  Tsutomu Kouyama,et al.  Crystal structure of squid rhodopsin , 2008, Nature.

[97]  C. Zhang,et al.  Covalent agonists for studying G protein-coupled receptor activation , 2014, Proceedings of the National Academy of Sciences.

[98]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[99]  Tetsuji Okada,et al.  Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. , 2007, Biophysical journal.

[100]  E. Pai,et al.  Opsin, a structural model for olfactory receptors? , 2013, Angewandte Chemie.

[101]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[102]  J. Simms,et al.  Lifting the lid on GPCRs: the role of extracellular loops , 2011, British journal of pharmacology.

[103]  T. Okada,et al.  Local peptide movement in the photoreaction intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.

[104]  A. Vahedi-Faridi,et al.  The High-Resolution Structure of Activated Opsin Reveals a Conserved Solvent Network in the Transmembrane Region Essential for Activation. , 2015, Structure.

[105]  Manfred Burghammer,et al.  Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.

[106]  Anton Barty,et al.  Native phasing of x-ray free-electron laser data for a G protein–coupled receptor , 2016, Science Advances.

[107]  W. Baumeister,et al.  Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex , 2018, Nature.

[108]  J. Shiloach,et al.  Structure of the agonist-bound neurotensin receptor , 2012, Nature.

[109]  Helgi B. Schiöth,et al.  Structural diversity of G protein-coupled receptors and significance for drug discovery , 2008, Nature Reviews Drug Discovery.

[110]  J. Klco,et al.  Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.

[111]  J. Renger,et al.  Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors , 2016, Nature Structural &Molecular Biology.

[112]  Paul R. Gerber,et al.  MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..

[113]  Bryan L. Roth,et al.  Molecular control of δ-opioid receptor signalling , 2014, Nature.

[114]  Yasuyuki Kihara,et al.  Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1 , 2015, Cell.

[115]  O. Nureki,et al.  X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog , 2017, Nature Structural &Molecular Biology.

[116]  A. J. Venkatakrishnan,et al.  Structural basis for chemokine recognition and activation of a viral G protein–coupled receptor , 2014, Science.

[117]  Jack Snoeyink,et al.  Scientific benchmarks for guiding macromolecular energy function improvement. , 2013, Methods in enzymology.

[118]  Jens Meiler,et al.  Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.

[119]  Hugh Rosen,et al.  Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.

[120]  W. Weis,et al.  Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis. , 2014, Structure.

[121]  Wouter Boomsma,et al.  Full cyclic coordinate descent: solving the protein loop closure problem in Cα space , 2005, BMC Bioinformatics.

[122]  David Baker,et al.  Protein structure prediction and analysis using the Robetta server , 2004, Nucleic Acids Res..

[123]  Bryan L. Roth,et al.  Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.

[124]  C. Murga,et al.  The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.

[125]  R. Stevens,et al.  The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor. , 2015, Structure.

[126]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[127]  Arthur Christopoulos,et al.  Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.

[128]  L. Pardo,et al.  Ligand-specific regulation of the extracellular surface of a G protein coupled receptor , 2009, Nature.

[129]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[130]  Ruben Abagyan,et al.  Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine , 2015, Science.

[131]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[132]  The cubicon method for concentrating membrane proteins in the cubic mesophase , 2017, Nature Protocols.

[133]  Wen-Hsin Lee,et al.  Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody , 2013 .

[134]  Bryan L. Roth,et al.  Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.

[135]  Ali Jazayeri,et al.  Crystal structure of the GLP-1 receptor bound to a peptide agonist , 2017, Nature.

[136]  A. Leslie,et al.  Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor , 2015, Molecular Pharmacology.

[137]  T. Okada,et al.  Crystallographic analysis of primary visual photochemistry. , 2006, Angewandte Chemie.

[138]  P. Stewart,et al.  Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism , 2017, Proceedings of the National Academy of Sciences.

[139]  Alexander S. Hauser,et al.  GPCRdb in 2018: adding GPCR structure models and ligands , 2017, Nucleic Acids Res..

[140]  Tomohiro Nishizawa,et al.  Activation mechanism of endothelin ETB receptor by endothelin-1 , 2016, Nature.

[141]  Jeffrey Skolnick,et al.  Fast procedure for reconstruction of full‐atom protein models from reduced representations , 2008, J. Comput. Chem..

[142]  G. V. van Westen,et al.  Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. , 2011, Trends in pharmacological sciences.

[143]  Gebhard F. X. Schertler,et al.  The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.

[144]  Ruben Abagyan,et al.  Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges. , 2014, Structure.